Physician profile
John C Pfeffer
NPI 1851456602
$74,759.46
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,257 · 2020: $18K · 2021: $27K · 2022: $8,774 · 2023: $4,633 · 2024: $7,720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $551 · Travel and Lodging: $204 · Education: $97.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,500.00 |
| Food and Beverage | $551.09 |
| Travel and Lodging | $204.49 |
| Education | $97.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $71,867.24 | 2019-2024 | Da Vinci Sp, Da Vinci Surgical System |
| Abbvie INC. | $626.19 | 2019-2022 | |
| Therapeuticsmd, INC. | $315.18 | 2019-2022 | |
| Astellas Pharma US INC | $297.71 | 2019-2024 | Veozah |
| Astrazeneca Pharmaceuticals LP | $213.46 | 2019-2024 | Lynparza |
| Hologic Sales and Service, LLC | $198.66 | 2019-2023 | Novasure |
| Pfizer INC. | $125.49 | 2019-2024 | |
| Caldera Medical, INC | $112.87 | 2023 | Desara |
| Urovant Sciences INC | $82.50 | 2021-2022 | |
| Ascend Therapeutics US, LLC | $78.59 | 2021-2022 | |
| Myovant Sciences INC. | $76.61 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $75.98 | 2019 | |
| Mayne Pharma Commercial LLC | $75.42 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $72.54 | 2020-2022 | |
| Allergan, INC. | $72.41 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $54.52 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $45.98 | 2021 | |
| Integra Lifesciences Corporation | $44.45 | 2022 | |
| Lupin INC. | $43.48 | 2020 | |
| Organon LLC | $40.75 | 2022 | |
| Coopersurgical, INC. | $32.28 | 2020-2021 | |
| Avion Pharmaceuticals | $30.99 | 2020 | |
| Evofem Biosciences, INC. | $29.26 | 2021 | |
| Roche Diagnostics Corporation | $22.83 | 2019 | |
| Lsi Solutions INC | $20.05 | 2020 | |
| Olympus America INC. | $19.81 | 2020 | |
| Agile Therapeutics, INC. | $19.26 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.16 | 2021 | |
| Vertical Pharmaceuticals, LLC | $17.99 | 2019 | |
| Exact Sciences Corporation | $16.02 | 2023 | Cologuard Collection Kit |
| Avanos Medical | $12.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pfeffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.